Icon

BUSULFEX (nda020954)- (6MG/ML)

BUSULFAN OTSUKA PHARM
6MG/ML
Yes No
2015-Nov-24 Expired
None None
None No
BUSULFEX is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
11 0 9
Total Other Developers 5
Drugs with Suitability No
6MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ***** ****** ******* *********** **** * & **** **, ***** *, ***** *, ************* ******* ******** **** (**** ), *******, *************, ****** ******* ******, ***** (***) ***
****** ************* *** ************* ***. *********** *** ********* ** *'*********, *******, ** *** ***, ****** (***) ***
****** ****** ****** ******** ******* ******* *********** **** **. *-*, *-*, *-**, *****-*** *******-********* ******-********* *************, *************, ** ******, ***** (***) ***
****** ****** ******** *** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ******** ****** *************** **., ***. *********** **.*-* ***** ****, ******* **-**** ************* ****** ****, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.